Literature DB >> 8433789

Magnetic resonance imaging of the brain in Wilson's disease.

K A Thuomas1, S M Aquilonius, K Bergström, K Westermark.   

Abstract

Fifteen patients with Wilson's disease were examined, using spin-echo (SE) and gradient-echo (GE) sequences with 0.5 T and 1.5 T magnetic resonance (MR) imagers. They fell into three groups: groups 1 and 2 were examined retrospectively after 3-18 years of treatment, while group 3 was examined prospectively from the start of treatment, after recommencement of treatment, or inadequate treatment. MRI was sensitive to changes in the basal ganglia at sites typical of Wilson's disease and was useful for documenting the effects of treatment. It was found necessary to estimate the relaxation times T1 and T2, to better assess improvement or transient worsening of the disease in the prospective group. Residual cavitation and gliosis could be distinguished in the retrospective group using a subtraction technique.

Entities:  

Mesh:

Year:  1993        PMID: 8433789     DOI: 10.1007/bf00593970

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  18 in total

1.  Aspects of image intensity and relaxation time assessment in magnetic resonance imaging. An experimental and clinical study.

Authors:  K A Thuomas
Journal:  Acta Radiol Suppl       Date:  1991

2.  Focal signal-intensity variations in the posterior internal capsule: normal MR findings and distinction from pathologic findings.

Authors:  S Mirowitz; K Sartor; M Gado; R Torack
Journal:  Radiology       Date:  1989-08       Impact factor: 11.105

3.  Errors in T2 estimation using multislice multiple-echo imaging.

Authors:  A P Crawley; R M Henkelman
Journal:  Magn Reson Med       Date:  1987-01       Impact factor: 4.668

4.  Nuclear magnetic resonance (NMR) imaging in Wilson disease.

Authors:  G A Lawler; J M Pennock; R E Steiner; W J Jenkins; S Sherlock; I R Young
Journal:  J Comput Assist Tomogr       Date:  1983-02       Impact factor: 1.826

5.  Changes in MR of malignant melanomas induced by glucose and fructose. A clinical and experimental investigation.

Authors:  P Naeser; K A Thuomas; A Roberto; B S Larsson
Journal:  Acta Radiol       Date:  1991-05       Impact factor: 1.990

6.  Tumour delineation with magnetic resonance imaging in gliomas. A comparison with positron emission tomography and computed tomography.

Authors:  M Tovi; K A Thuomas; K Bergström; A Lilja; M Bergström; H Lundqvist; B Långström
Journal:  Acta Radiol Suppl       Date:  1986

7.  Unusual MR findings in CNS Wilson disease.

Authors:  W T Yuh; F W Flickinger
Journal:  AJR Am J Roentgenol       Date:  1988-10       Impact factor: 3.959

8.  Clinical assessment of 31 patients with Wilson's disease. Correlations with structural changes on magnetic resonance imaging.

Authors:  S Starosta-Rubinstein; A B Young; K Kluin; G Hill; A M Aisen; T Gabrielsen; G J Brewer
Journal:  Arch Neurol       Date:  1987-04

9.  Wilson's disease. Clinical correction with cranial computed tomography.

Authors:  B E Kendall; S S Pollock; N M Bass; A R Valentine
Journal:  Neuroradiology       Date:  1981       Impact factor: 2.804

10.  Comparison of functional and structural brain disturbances in Wilson's disease.

Authors:  G Grimm; L Prayer; W Oder; P Ferenci; C Madl; P Knoflach; B Schneider; H Imhof; A Gangl
Journal:  Neurology       Date:  1991-02       Impact factor: 9.910

View more
  14 in total

1.  MRI in patients with general paresis.

Authors:  U Zifko; D Wimberger; K Lindner; G Zier; W Grisold; E Schindler
Journal:  Neuroradiology       Date:  1996-02       Impact factor: 2.804

2.  Wilson's disease: cranial MRI observations and clinical correlation.

Authors:  S Sinha; A B Taly; S Ravishankar; L K Prashanth; K S Venugopal; G R Arunodaya; M K Vasudev; H S Swamy
Journal:  Neuroradiology       Date:  2006-06-03       Impact factor: 2.804

Review 3.  Neuroimaging in Wilson disease.

Authors:  H N van Wassenaer-van Hall
Journal:  Metab Brain Dis       Date:  1997-03       Impact factor: 3.584

Review 4.  Neurologic impairment in Wilson disease.

Authors:  Petr Dusek; Tomasz Litwin; Anna Członkowska
Journal:  Ann Transl Med       Date:  2019-04

5.  MR imaging of the brain in Wilson disease of childhood: findings before and after treatment with clinical correlation.

Authors:  T J Kim; I O Kim; W S Kim; J E Cheon; S G Moon; J W Kwon; J K Seo; K M Yeon
Journal:  AJNR Am J Neuroradiol       Date:  2006 Jun-Jul       Impact factor: 3.825

6.  Wilson's disease: neurological and magnetic resonance imaging improvement on zinc treatment.

Authors:  J M Heckmann; R W Eastman; J C De Villiers; R Hewlett
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-10       Impact factor: 10.154

7.  MR Imaging of the Brain in Neurologic Wilson Disease.

Authors:  X-E Yu; S Gao; R-M Yang; Y-Z Han
Journal:  AJNR Am J Neuroradiol       Date:  2019-01       Impact factor: 3.825

8.  Proton MR spectroscopy in Wilson disease: analysis of 36 cases.

Authors:  Leandro T Lucato; Maria Concepción G Otaduy; Egberto R Barbosa; Alexandre A C Machado; Alexander McKinney; Luiz A Bacheschi; Milberto Scaff; Giovanni G Cerri; Claudia C Leite
Journal:  AJNR Am J Neuroradiol       Date:  2005-05       Impact factor: 3.825

9.  Wilson's disease: two treatment modalities. Correlations to pretreatment and posttreatment brain MRI.

Authors:  Maria do Desterro Leiros da Costa; Mariana Spitz; Luiz Alberto Bacheschi; Claudia Costa Leite; Leandro Tavares Lucato; Egberto Reis Barbosa
Journal:  Neuroradiology       Date:  2009-05-29       Impact factor: 2.804

10.  Dopamine D2 receptor binding and cerebral glucose metabolism recover after D-penicillamine-therapy in Wilson's disease.

Authors:  G Schlaug; H Hefter; B Nebeling; V Engelbrecht; P Weiss; G Stöcklin; R J Seitz
Journal:  J Neurol       Date:  1994-10       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.